ENDOSURE, INC. was founded based on a new approach to empower physicians with the tools they need for earlier, more accurate endometriosis diagnosis.

To that end, we proudly offer the ENDOSURE TEST, the first and only Tier-1 diagnostic test for endometriosis. Since its introduction in 2022, this groundbreaking clinical support tool has already begun to shift the entire paradigm in how medical providers detect and treat endometriosis.

The ENDOSURE TEST meets all major requirements of a Tier-1 diagnostic test, offering critical advantages:

🔹️ Low cost

🔹️ Easy-to-use

🔹️ Non-invasive

🔹️ Rapid results (30 minutes)

🔹️ Highly accurate (surgically verified)

🔹️ No population-related use restriction (detects disease in patients of any age, at any stage, anywhere in the anatomy)

The ENDOSURE TEST is actively being used in many gynecology practices around the world, equipping medical providers with the means to detect endometriosis at its earliest stages and offer targeted, personalized therapy to their patients.

At ENDOSURE, INC., we are committed to a future in endometriosis care where timely diagnosis is no longer a barrier to effective disease management, and no woman must wait nearly a decade for a definitive diagnosis.

EndoSure, Inc.

Dr. Mark Noar

This department is responsible for the overall strategic direction, compliance, and governance of the organization.

EndoSure, Inc.

Org chart

Teams

Executive Leadership

Offices